期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

氯吡格雷抵抗研究新进展 被引量：4

原文传递
导出
摘要 氯吡格雷是新型抗血小板药物，通过阻断血小板腺苷二磷酸（adenosine diphosphate，ADP）受体途径抑制血小板聚集，可减少急性冠状动脉综合征（acute coronary syndrome，ACS）和经皮冠状动脉介入术（percutaneous coronary interventions，PCI）患者的心血管事件。
作者 王佳旺(综述) 刘凡(审校)
机构地区 河北医科大学第二医院心内科
出处 《中国综合临床》 2013年第4期444-447,共4页 Clinical Medicine of China
关键词 氯吡格雷抵抗 基因多态性 细胞色素
分类号 R541 [医药卫生—心血管疾病]
  • 相关文献

参考文献31

  • 1Kazui M, Nishiya Y, Ishizuka T, et al. Identification of the human cytochrome 17450 enzymes involved in the two oxixtative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite [ J]. Drug Metab Dispos,2010,38 (1) :92-99.
  • 2Simon T, Verstuyft C, Mary-Krause M, et al. Genetic determinants of response to clopidogrel and cardiovascular events [J]. N Engl J Med ,2009,360(4 ) :363-375.
  • 3Chen ZM, Jiang LX, Chen YP, et al. Addition of elopidogrel to aspirin in 45, 852 patients with acute myocardial infarction: randomised placebo - controlled trial [J]. Lancet, 2005, 366 ( 9497 ) : 1607 -1621.
  • 4Savi P,Herbert JM. Clopidogrel and tielopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis [ J]. Semin Thromb I-Iemost, 2005,31 ( 2 ) : 174- 183.
  • 5Wiviott SD, Braunwald E, McCabe CH, et al. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON- TIMI 38 trial: a subanalysis of a randomised trial [J]. Lancet, 2008,371 (9621) :1353-1363.
  • 6Sabatine MS, Cannon CP, Gibson CM, et al. Addition of elopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST- segment elevation [ J ]. N Engl J Med,2005,352 ( 12 ) : 1179-1189.
  • 7Sugunaraj JP, Palaniswamy C, Selvaraj DR, et al. Clopidogrel resistance [ J ]. Am J Ther,2010,17 (2) :210-215.
  • 8Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence [ J ]. J Am Coil Cardio1,2005,45 ( 8 ) : 1157- 1164.
  • 9Selwyn AP. Prothrombotic and antithrombotic pathways in acutecoronary syndromes [ J ]. Am J Cardio1,2003,91 (12A) :3H-11H.
  • 10Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence [ J]. J Am Coll Cardiol,2005,45 ( 8 ) : 1157- 1164.

二级参考文献13

  • 1FONTANA P, DUPONT A, GANDRILLE S, et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects [ J ]. Circulation,2003, 108(8):989 -995.
  • 2MEHTA SR, YUSUF S, PETERS RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study[J]. Lancet, 2000, 358(9281):527 -533.
  • 3YUSUF S, ZHAO F, MEHTA SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-elevation[ J ]. N Engl J Med , 2001, 345 (7) :494 -502
  • 4NGUYEN TA, DIODATI JG, PHARAND C. Resistance to clopidogrel : a review of the evidence[ J]. J Am Coll Cardiol, 2005, 45(8) :1157 -1164.
  • 5VON BECKERATH N, VON BECKERATH O, KOCH W, et al. P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose [ J ]. Blood Coagul Fibrinolysis, 2005, 16 ( 3 ) : 199 - 204.
  • 6ANGIOLILLO DJ, FERNANDEZ-ORTIZ A, BERNARDO E, et al. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease[J]. Thromb Res, 2005, 116(6) :491 -497.
  • 7BLIN N, STAFFORD DW. A general method for isolation of high molecular weight DNA from eukaryotes [ J ]. Nucleic Acids Res, 1976, 3(9) :2303 -2308.
  • 8LAU WC, GURBEL PA, WATKINS PB, et al. Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance [ J ]. Circulation, 2004, 109 ( 2 ) :166 -171.
  • 9TAUBERT D, VON BECKERATH N, GRIMBERG G, et al. Impact of P-glycoprotein on clopidogrel absorption [ J ]. Clin Pharmacol Ther, 2006, 80(5 ):486-501.
  • 10TAUBERT D, KASTRATI A, HARLFINGER S, et al. Pharmacokinetics of clopidogrel after administration of high loading dose [J]. Thromb Haemost, 2004, 92(2) :311 -316.

共引文献9

同被引文献40

  • 1郝盼盼,陈玉国,张运.氯吡格雷抵抗相关因素的研究进展[J].心血管病学进展,2009,30(6):991-994. 被引量：21
  • 2Xian-Feng Liu,Jian Cao,Li Fan,Lin Liu,Jian Li,Guo-Liang Hu,Yi-Xin Hu,Xiao-Li Li.Prevalence of and risk factors for aspirin resistance in elderly patients with coronary artery disease[J].Journal of Geriatric Cardiology,2013,10(1):21-27. 被引量：11
  • 3无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量：2072
  • 4柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量：2146
  • 5Foley TR, Waldo SW, Armstrong EJ. Antithrombotic therapy inperipheral artery disease [J]. Vase Med, 2016,21 (2) : 156-69. doi: 10. 1177/1358863X15622987.
  • 6Brendel K, Weigel G,Griesmacher A, et al. Low prevalence ofclopidogrel and acetylsalicylic acid resistance in patients withacutemyocardial infarction and pantoprazole treatment in everydaypractice [J]. Int J Cmliol,2013,168 ( 1 ): 589-590. doi :10. 1016/j. ijcard. 2013. 01. 246..
  • 7Rapezzi Claudio,Biagini Elena,Branzi Angelo. Guidelines for thediagnosis and treatment of non-ST-segment elevation acute coronarysyndromes : the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the EuropeanSociety of Cardiology [J].Eur Heart J,2008,29(2) :277-278.
  • 8Yusuf S,Zhao F,Mehta SR,et al. Effects of clopidogrel in additionto aspirin in patients with acute coronary syndromes without ST-segment elevation [J]. N Engl J Med,2001,345(7) :494-502.
  • 9Mehta SR,Yusuf S, Peters RJ, et al. Effects of pretreatment withclopidogrel and aspirin followed by long-term therapy in patientsundergoing percutaneous coronary intervention : the PCI-CUREstudy [J].Lancet,2001,358(9281) :527-533.
  • 10Xie X, Ma YT, Yang YN, et al. CYP2C19 phenotype, stentthrombosis,myocanJial infarction, and mortality in patients withcoronary stent placement in a Chinese population [ J]. PLoS One,2013,8(3) :e59344.doi: 10.1371/joumal.pone.0059344.

引证文献4

二级引证文献56

中国综合临床
2013年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部